Cargando…
Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD)
Benzoporphyrin derivative monoacid ring A (BPD-MA, verteporfin) is currently under investigation as a photosensitizer for photodynamic therapy (PDT). Since BPD exhibits rapid pharmacokinetics in plasma and tissues, we assessed damage to tumour and muscle microvasculature when light treatment for PDT...
Autores principales: | Fingar, V H, Kik, P K, Haydon, P S, Cerrito, P B, Tseng, M, Abang, E, Wieman, T J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362794/ https://www.ncbi.nlm.nih.gov/pubmed/10206280 http://dx.doi.org/10.1038/sj.bjc.6690271 |
Ejemplares similares
-
High efficiency of benzoporphyrin derivative in the photodynamic therapy of pigmented malignant melanoma
por: Busetti, A, et al.
Publicado: (1999) -
Photosensitising potency of structural analogues of benzoporphyrin derivative (BPD) in a mouse tumour model.
por: Richter, A. M., et al.
Publicado: (1991) -
Reactive oxygen species explicit dosimetry to predict tumor growth for benzoporphyrin derivative-mediated vascular photodynamic therapy
por: Sheng, Tianqi, et al.
Publicado: (2020) -
Unraveling the Photodynamic Activity of Cationic Benzoporphyrin-Based Photosensitizers against Bladder Cancer Cells
por: Gomes, Ana T. P. C., et al.
Publicado: (2021) -
Validation of combined Monte Carlo and photokinetic simulations for the outcome correlation analysis of benzoporphyrin derivative-mediated photodynamic therapy on mice
por: Beeson, Karl W., et al.
Publicado: (2019)